United States· US:84167-411_518abf2b-6ac9-ab9b-e063-6294a90ae693
APUREE Nailtific Maximum Strength Dual-Action Antifungal Pen Pro
A medicinal product containing undecylenic acid; tolnaftate, registered in United States by Guangzhou Meixi Biotechnology Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- UNDECYLENIC ACID; TOLNAFTATE
- Manufacturer
- Guangzhou Meixi Biotechnology Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184167411022 APPLICATOR in 1 BOX (84167-411-02) / 6 LIQUID in 1 APPLICATOR
- ndc1184167-411-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/842f45fd-2e45-4289-86bd-bbfba69fdfec GET /v1/drugs/842f45fd-2e45-4289-86bd-bbfba69fdfec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".25; 1",
"substance": "UNDECYLENIC ACID; TOLNAFTATE",
"productndc": "84167-411",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/1; g/1",
"application_number": "M005",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about undecylenic acid; tolnaftate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.